Neutral
Vanguard Capital Management (RYTM) files Schedule 13G for 5.02% stake
Vanguard Capital Management has filed a Schedule 13G, disclosing a 5.02% beneficial ownership stake in Rhythm Pharmaceuticals Inc. The filing indicate...